BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26671997)

  • 1. GHRH excess and blockade in X-LAG syndrome.
    Daly AF; Lysy PA; Desfilles C; Rostomyan L; Mohamed A; Caberg JH; Raverot V; Castermans E; Marbaix E; Maiter D; Brunelle C; Trivellin G; Stratakis CA; Bours V; Raftopoulos C; Beauloye V; Barlier A; Beckers A
    Endocr Relat Cancer; 2016 Mar; 23(3):161-70. PubMed ID: 26671997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism.
    Daly AF; Beckers A
    Endocr Rev; 2024 May; ():. PubMed ID: 38696651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.
    Caruso M; Mazzatenta D; Asioli S; Costanza G; Trivellin G; Franke M; Abboud D; Hanson J; Raverot V; Pétrossians P; Beckers A; Cappa M; Daly AF
    Front Endocrinol (Lausanne); 2024; 15():1345363. PubMed ID: 38481440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
    Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
    J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked acrogigantism syndrome: clinical profile and therapeutic responses.
    Beckers A; Lodish MB; Trivellin G; Rostomyan L; Lee M; Faucz FR; Yuan B; Choong CS; Caberg JH; Verrua E; Naves LA; Cheetham TD; Young J; Lysy PA; Petrossians P; Cotterill A; Shah NS; Metzger D; Castermans E; Ambrosio MR; Villa C; Strebkova N; Mazerkina N; Gaillard S; Barra GB; Casulari LA; Neggers SJ; Salvatori R; Jaffrain-Rea ML; Zacharin M; Santamaria BL; Zacharieva S; Lim EM; Mantovani G; Zatelli MC; Collins MT; Bonneville JF; Quezado M; Chittiboina P; Oldfield EH; Bours V; Liu P; W de Herder W; Pellegata N; Lupski JR; Daly AF; Stratakis CA
    Endocr Relat Cancer; 2015 Jun; 22(3):353-67. PubMed ID: 25712922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.
    Cuttler L; Jackson JA; Saeed uz-Zafar M; Levitsky LL; Mellinger RC; Frohman LA
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1148-54. PubMed ID: 2498385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
    Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli.
    Glikson M; Gil-Ad I; Galun E; Dresner R; Zilberman S; Halperin Y; Okon E; Laron Z; Rubinow A
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):366-71. PubMed ID: 1683501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gigantism: X-linked acrogigantism and GPR101 mutations.
    Iacovazzo D; Korbonits M
    Growth Horm IGF Res; 2016; 30-31():64-69. PubMed ID: 27743704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G
    Abboud D; Daly AF; Dupuis N; Bahri MA; Inoue A; Chevigné A; Ectors F; Plenevaux A; Pirotte B; Beckers A; Hanson J
    Nat Commun; 2020 Sep; 11(1):4752. PubMed ID: 32958754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.
    Franke M; Daly AF; Palmeira L; Tirosh A; Stigliano A; Trifan E; Faucz FR; Abboud D; Petrossians P; Tena JJ; Vitali E; Lania AG; Gómez-Skarmeta JL; Beckers A; Stratakis CA; Trivellin G
    Am J Hum Genet; 2022 Apr; 109(4):553-570. PubMed ID: 35202564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
    Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.